Soft tissue tumors and treatment
Soft tissue tumors and treatment is a research topic within Pathology and Forensic Medicine. Science Explorer counts 9.1k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the clinical, molecular, and genetic characteristics of glomus tumors, including atypical and malignant variants. It covers topics such as diagnosis, imaging modalities, surgical approaches, and the association with neurofibromatosis type 1.
- Glomus Tumors
- Angioleiomyoma
- Gastrointestinal Glomus Tumors
- Malignant Glomus Tumor
- Genetic Mutations
- Clinical Diagnosis
- Radiological Imaging
- Surgical Treatment
- Soft Tissue Tumors
- Neurofibromatosis Type 1
- Research works
- 9.1k fractional, since 1950
- In the world top 10%
- 923 per year above
- Top-10% rate
- 10.2% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +9% the tick is no change
- Largest producer
United States
28% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Soft tissue tumors and treatment research?
By volume, the United States and India publish the most (302 and 227 works in 2022-now).
By volume, 2022-now
- 1
United States
302 works
- 2
India
227 works
- 3
China
186 works
- 4
Japan
104 works
- 5
Spain
54 works
- 6
Brazil
51 works
- 7
Italy
44 works
- 8
South Korea
44 works
- 9
United Kingdom
42 works
- 10
Türkiye
41 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Soft tissue tumors and treatment research?
By volume in 2022-now, All India Institute of Medical Sciences publishes the most Soft tissue tumors and treatment research, followed by Mayo Clinic and Sichuan University.
By volume, 2022-now
- 1
All India Institute of Medical SciencesIndia
24 works
- 2
Mayo ClinicUnited States
14 works
- 3
Sichuan UniversityChina
11 works
- 4
Harvard UniversityUnited States
11 works
- 5
University of DelhiIndia
10 works
- 6
Peking UniversityChina
8 works
- 7
Banaras Hindu UniversityIndia
7 works
- 8
Cornell UniversityUnited States
7 works
- 9
Dr. D. Y. Patil Medical College, Hospital and Research CentreIndia
6 works
- 10
Universidade de São PauloBrazil
6 works
Who are the leading researchers in Soft tissue tumors and treatment?
The most-cited researchers publishing on Soft tissue tumors and treatment include Marc Ladanyi and Ralph H. Hruban.
- 1
Marc Ladanyi
United States
217k citations
- 2
Ralph H. Hruban
United States
209k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Soft tissue tumors and treatment research done?
The largest centres of Soft tissue tumors and treatment research in 2022-now are New Delhi (India), Beijing (China), Seoul (South Korea) and Tokyo (Japan). Among places with at least 20 works in it, it is an unusually large share of all research in New Delhi.
Largest cities, 2022-now
Where it is the local speciality
- New DelhiIN · 31.3 works4.3×
Location quotient: how much more of its research is in Soft tissue tumors and treatment than the world average.
Where is the best place to study Soft tissue tumors and treatment?
Among universities, judged by research, All India Institute of Medical Sciences, Harvard University and Sichuan University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | All India Institute of Medical SciencesIndia |
57.1 | 10.8% | 15.6× | 24 | +132.3% |
| 2 | Harvard UniversityUnited States |
53.9 | 35.7% | 2.5× | 11 | -13.9% |
| 3 | Sichuan UniversityChina |
35.6 | 20.5% | 3.6× | 11 | +44.1% |
| 4 | University of DelhiIndia |
21.0 | 3.8% | 10.7× | 10 | +39.9% |
Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Soft tissue tumors and treatment, country by countryIs Soft tissue tumors and treatment research growing?
Output in 2022-2025 was 9% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Soft tissue tumors and treatment.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Soft tissue tumors and treatment as a percentage of every work published that year, 0.0066% in 2024.
Fractional works of Soft tissue tumors and treatment over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Soft tissue tumors and treatment. Posts are plain text and can be reported.